期刊文献+

肺源性心脏病心力衰竭患者BNP、CRP变化水平及其临床意义 被引量:2

Changes in levels of BNP and CRP in patients of chronic pulmonary heart disease with cardiac failure and its clinical significance
下载PDF
导出
摘要 目的探讨肺源性心脏病不同程度心力衰竭患者脑钠肽(BNP)和C反应蛋白(CRP)的变化及其临床意义。方法将158例肺源性心脏病患者进行心功能分级,分别为Ⅰ级、Ⅱ级、Ⅲ级和Ⅳ级,应用双抗夹心免疫酶法与胶乳凝集反应法测定所有患者血浆BNP浓度及血浆C反应蛋白(CRP)浓度;心脏多普勒超声检查心脏左室射血分数(EF)、肺动脉平均压(MPAP)、右心室内径(RVID);胸部正位片测定右肺下动脉直径。结果血浆BNP随心衰程度的加重而显著增加,MPAP上升,RVID增加,EF下降,CRP增加,右肺下动脉直径增加,各级心功能组间的差异均有统计学意义(P<0.05)。结论肺源性心脏病患者血浆BNP浓度随着心衰程度加重而上升,与EF、MPAP、RVID、CRP、右肺下动脉直径等直接相关。 Objective To investigate the changes in the levels of brain natriuretic peptide(BNP) in patients of chronic pulmonary heart disease(CPHD) with different degrees of heart failure.Methods According to New York Heart Association(NYHA) functional classification,158 patients of CPHD were divided into four groups: gradeⅠ,gradeⅡ,gradeⅢ,and gradeⅣ.The concentration of BNP and C-reactive protein(CRP) were measured by ELISA and Latex Agglutination Method.The left ventricular ejection fraction(EF),mean pulmonary artery pressure(MPAP),and right ventricular internal diameter(RVID) were detected by heart Doppler Ultrasonic,and the diameter of the right lower pulmonary artery was measured by Chest X-ray.Results The levels of plasma BNP increased significantly as the degree of heart failure aggravated.At the same time,the levels of MPAP elevated significantly,with levels of RVID increased significantly,EF descended significantly,CRP increased significantly,and the diameter of the right lower pulmonary artery increased significantly(P〈0.05).Conclusion The levels of plasma BNP in patients of CPHD increased significantly along with the aggravation of the heart failure,which showed a direct correlation with BNP,EF,MPAP,RVID,CRP,and the diameter of the right lower pulmonary artery.
出处 《海南医学》 CAS 2011年第21期20-22,共3页 Hainan Medical Journal
关键词 肺源性心脏病 脑钠肽 Chronic pulmonary heart disease(CPHD) Brain natriuretic peptide(BNP)
  • 相关文献

参考文献8

二级参考文献25

  • 1王家宏,黄永麟.脑钠肽在心力衰竭诊治中的应用进展[J].中国实用内科杂志,2005,25(7):657-658. 被引量:21
  • 2贺桦,许顶立,刘彦波,屠燕.慢性心力衰竭患者血清CRP水平的变化及临床意义[J].中国分子心脏病学杂志,2004,4(2):114-117. 被引量:13
  • 3贺平.超敏C-反应蛋白在心血管疾病的研究进展[J].华夏医学,2006,19(6):1293-1295. 被引量:5
  • 4Mareeio E, Ochiai A, Antonio CP, et al. Utic acid renal excretion and renal insufficiency in decompens ated servere heart failure. The European Journal of Heart Failure, 2005,7 ( 2 ) :468 -474.
  • 5Ridker PM. High-sensitivity C-reactive protein:potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation ,2001,103 ( 13 ) : 1813-1818.
  • 6Rifai N, Ridker PM. High sensitivity C-reactive protein : anovel and promising marker of coronary heart disease. Clin Chem, 2001,47 (9) :403 -411.
  • 7Rifai N,Tracy RP, Ridker PM. Clinical efficacy of an automated high sensitivity C-reactive protein assay. Clin Chem, 1999, 45 (12) : 2136-2141.
  • 8Benzaquen LR, YU H, Rifai N. High sensitivity C-reactive protein : an emerging role in cardiovascular risk assessment. Crit Rev Clin Lab Sci ,2002,39 (4-5) :459-497.
  • 9Gomesm C. C-reactive protein: a new golden marker of caidiovascular risk. Rev Port Cardiol,2002, 21 ( 11 ) : 1329-1346.
  • 10Fabrizio Montecucco, Francois Mach. New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor. Clin Interv Aging, 2008,3 ( 2 ) : 341-349.

共引文献5134

同被引文献14

  • 1Yandle T G. Biochemistry of natriuretic peptides [J]. J Intern Med, 1994,235(6) :561-571.
  • 2Eren N K, Ertas F, Ytiksek U, et al. Additive prognostic value of NT-proBNP over TIME risk score in intermediate- risk patients with acute coronary syndrome [J]. Turk Kardiyol Dem Ars, 2009,37(1) : 1-8.
  • 3Mitrovic V, Luss H, Nitsche K, et al. Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: a double-blind, placebo- controlled, ascending-dose trial [J]. Am Heart J, 2005,150 (6) : 1239.
  • 4Mueller C, Breidthardt T, Laule Kilian K, et al. The integration of BNP and NT-proBNP into clinical medicine [J], Swiss Med Wkly, 2007,137(1-2) :4-12.
  • 5Bhattacharyya S, Toumpanakis C, Caplin M E, et al. Usefulness of N-terminal pro-brain natriuretic peptide as a biomarker of the presence of carcinoid heart disease [J]. Am J Cardiol, 2008, 102(7) :938-942.
  • 6Vogelsang T W, Jensen R J, Monrad A L, et al. Independent effects of both right and left ventricular function on plasma brain natriuretic peptide [J]. Eur J Heart Fail, 2007,9(9): 892-$96.
  • 7Hunt SA,Abraham WT,Chin MH. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult[J].Circulation,2005,(12):154-235.
  • 8Payne CJ,Gibson SC,Bryce G. B-type natriuretic peptide predicts long-term survival after major non-cardiac surgery[J].British Journal of Anaesthesia,2011,(02):144-149.
  • 9肖军,唐发宽,张伟,常青,关长勇,杨波,郑方,李州利,陆宏.BNP与Goldman评分评价老年非心脏手术心血管事件的比较[J].心脏杂志,2008,20(2):201-203. 被引量:6
  • 10付明,谭虹,周颖玲,申俊君.组织多普勒Tei指数和脑钠肽联合评价急诊急性冠脉综合征患者心功能的临床研究[J].实用医学杂志,2010,26(14):2497-2500. 被引量:7

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部